A 38-year-old man from Mumbai undergoes total thyroidectomy for a 3 cm papillary thyroid carcinoma (PTC) with no extrathyroidal extension or lymph node involvement (Stage I). Histology confirms classical variant PTC. Postoperative TSH is 2.5 mIU/L. What is the most appropriate next step in management?

Risk Stratification in Papillary Thyroid Carcinoma

This patient has low-risk PTC (Stage I: <4 cm, no extrathyroidal extension, no lymph node involvement, classical variant). Risk stratification determines the intensity of follow-up and need for radioactive iodine (RAI).

Management by Risk Category

Key Point:

Low-risk PTC does NOT routinely require radioactive iodine ablation. TSH suppression to 0.5–2 mIU/L (mild suppression) is appropriate, with surveillance by thyroglobulin and ultrasound.

High-Yield:

ATA 2015 Guidelines: RAI ablation is not recommended for low-risk PTC (Stage I, no high-risk features). Aggressive TSH suppression (<0.1 mIU/L) is reserved for high-risk disease and increases cardiovascular and bone morbidity without clear benefit in low-risk patients.

Clinical Pearl:

Thyroglobulin is an excellent tumor marker in PTC. Undetectable thyroglobulin on levothyroxine monotherapy with normal ultrasound is reassuring and indicates excellent prognosis in low-risk disease. Serial measurement guides follow-up intensity.

Loading illustration…